linda yaccarino emed - Search News

News

Linda Yaccarino, Elon Musk and Weight-Loss Drug

Insider on MSN · 3d

Linda Yaccarino is ditching Musk world for weight-loss drugs. It makes total sense.

Linda Yaccarino was named CEO of EMed, a telehealth company, a turn for someone who's made her name in media.

Variety on MSN · 3d

Linda Yaccarino, After Exiting Elon Musk’s X, Tapped as CEO of Weight-Loss Drug Management Company eMed

Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform for GLP-1/GIP population health management.” That refers to the class of weight-loss drugs like Wegovy and Ozempic.

Former X CEO Linda Yaccarino named top exec of weight-loss company

Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk controversy, has been named the top executive at health company eMed. eMed Population Health provides support for patients on GLP-1 medications,

4don MSN

Linda Yaccarino joins health tech platform eMed as CEO after leaving X

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

4don MSN

Former X CEO Yaccarino takes helm at GLP-1 focused telehealth firm eMed

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results